Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. Business Wire LOS ANGELES -- June 12, 2013 The Law Offices of Todd M. Garber announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of a class (the “Class”) comprising all purchasers of the securities of AVEO Pharmaceuticals, Inc. (“AVEO” or the “Company”) (NASDAQ: AVEO) between January 3, 2012 and May 1, 2013, inclusive (the “Class Period”). AVEO engages in discovering, developing, and commercializing targeted cancer therapies. The Complaint alleges that defendants issued materially false and misleading statements throughout the Class Period regarding the Phase III trial design and results for the Company’s drug Tivopath, or tivozanib, for the treatment of advanced kidney cancer. Specifically, defendants misrepresented or failed to disclose that: (1) the U.S. Food and Drug Administration had recommended that the Company conduct an additional Phase III trial due to adverse trends in the Company’s first Phase III trial; (2) there was a 25% higher rate of death associated with tivozanib therapy compared to the control drug, sorafenib; and (3) almost 90% of patients studied in the single Phase III trial were enrolled from sites in Central and Eastern Europe with inconsistent treatment patterns from those in the United States. If you are a member of the above-described Class, you may move the Court no later than July 8, 2013 to serve as lead plaintiff; however, you must meet certain legal requirements. To be a member of the Class you need not take any action at this time, or you may retain counsel of your choice. If you have information or would like to learn more about these claims, or if you purchased AVEO stock prior to the Class Period and have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Todd M. Garber, Esquire, of the Law Offices of Todd M. Garber, by telephone at 213-700-7262 or by email to firstname.lastname@example.org. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contact: Law Offices of Todd M. Garber Todd M. Garber, Attorney at Law Los Angeles, California 213-700-7262 email@example.com